The Cancer Therapy Prescribing Course is a comprehensive, CE-accredited course for nurse practitioners, PAs, and pharmacists benchmarking the education that advanced practitioners need to safely prescribe cancer therapy. Topics include chemotherapy, targeted therapy, and immunotherapy prescribing best practices.

This course covers the basics of cancer biology and genetics, including cancer characteristics, carcinogenesis, oncogenes, tumor suppressor genes, and cellular signaling pathways. It also addresses genetic testing for hereditary cancer syndromes and tumor genomic profiling, with insights into future developments, report information, and somatic variant–drug pairs.

The Advanced Practitioner Radiation Oncology (APRO) course is a specialized, in-depth program designed for advanced practitioners seeking to enhance their knowledge and clinical expertise in radiation oncology. This course provides a comprehensive understanding of radiation biology, treatment planning, disease-specific management, and patient-centered care, equipping participants with the skills to improve patient outcomes in a multidisciplinary setting.

The Diversity, Equity, and Inclusion in Oncology modules by APSHO include 8 comprehensive and self-paced modules to equip you with the understanding of health disparities, inequities and structural racism in the hematology/oncology setting and how these affect patient outcomes. (Additionally, one of the modules addresses health disparities and inequities in substance use disorders and this module meets the DEA requirement for training on substance use disorder.) 3.5 CE-Accredited Hours

This introductory course offers advanced practitioners a foundational understanding of genomics in oncology. Participants will explore how genetic alterations contribute to cancer development, learn about key biomarker testing methods, and understand the role of genomic profiling in guiding targeted therapy and monitoring treatment resistance